OptiBiotix Health (LON:OPTI) Shares Down 0.8% – Time to Sell?

OptiBiotix Health Plc (LON:OPTI) dropped 0.8% on Wednesday . The company traded as low as GBX 17.37 ($0.21) and last traded at GBX 17.37 ($0.21). Approximately 27,744 shares traded hands during trading, a decline of 76% from the average daily volume of 114,657 shares. The stock had previously closed at GBX 17.50 ($0.22).

OptiBiotix Health Trading Down 0.8 %

The company has a 50 day moving average of GBX 15.82 and a 200 day moving average of GBX 18.22. The firm has a market cap of £17.01 million, a price-to-earnings ratio of -578.83 and a beta of 1.71. The company has a current ratio of 6.18, a quick ratio of 7.89 and a debt-to-equity ratio of 4.51.

OptiBiotix Health Company Profile

OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome – the collective genome of the microbes in the body – in order to prevent and manage human disease and promote wellness.

OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements.